Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | OTC | P00480 | 1/20 | 0.50 |
| ▸ | NOS2 | P35228 | 7/20 | 0.49 |
| ▸ | NOS1 | P29475 | 5/20 | 0.49 |
| ▸ | NOS3 | P29474 | 4/20 | 0.49 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.47 |
| ▸ | ARG2 | P78540 | 4/20 | 0.47 |
| ▸ | ARG1 | P05089 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43287 | 1.00 | GSR (0.52) | GSROTCNOS2NOS1NOS3 | |
| SCHEMBL28754154 | 1.00 | GSR (0.52) | GSROTCNOS2NOS1NOS3 | |
| SCHEMBL10071054 | 1.00 | GSR (0.52) | GSROTCNOS2NOS1NOS3 | |
| SCHEMBL27615800 | 1.00 | GSR (0.52) | GSROTCNOS2NOS1NOS3 | |
| Arginine SCHEMBL5152371 | 0.98 | OTC (0.53) | GSROTCNOS2NOS1NOS3 | |
| SCHEMBL4221548 | 0.98 | GSR (0.50) | GSROTCNOS2NOS1NOS3 | |
| SCHEMBL4225929 | 0.98 | GSR (0.50) | GSROTCNOS2NOS1NOS3 | |
| SCHEMBL4225043 | 0.98 | GSR (0.50) | GSROTCNOS2NOS1NOS3 | |
| Hydrochloric Acid SCHEMBL21045047 | 0.98 | GSR (0.50) | GSROTCNOS2NOS1NOS3 | |
| SCHEMBL4405593 | 0.98 | GSR (0.50) | GSROTCNOS2NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240101602-A1 | ANTIMICROBIAL PEPTIDES AND METHOD OF PREVENTING OR TREATING INFECTION BY USING THE SAME | NATIONAL TAIWAN UNIVERSITY (TW) | 2024-03-28 | — | — | US | claimed |
| EP-4251277-A1 | ANTIMICROBIAL PEPTIDES AND METHOD OF PREVENTING OR TREATING INFECTION BY USING THE SAME | Academia Sinica (TW) | 2023-10-04 | — | — | EP | claimed |
| WO-2022115510-A1 | ANTIMICROBIAL PEPTIDES AND METHOD OF PREVENTING OR TREATING INFECTION BY USING THE SAME | ACADEMIA SINICA (TW) | 2022-06-02 | — | — | WO | claimed |
| CN-111621267-B | Environment-friendly hyperbranched poly-guano acid shale intercalation inhibitor | 西南石油大学 | 2022-04-01 | — | — | CN | claimed |
| US-11124818-B2 | Method for modifying microcystins and nodularins | CYANO BIOTECH GMBH (DE) | 2021-09-21 | — | — | US | claimed |
| US-20200377922-A1 | METHOD FOR MODIFYING MICROCYSTINS AND NODULARINS | CYANO BIOTECH GMBH (DE) | 2020-12-03 | — | — | US | claimed |
| CN-111621267-A | Environment-friendly hyperbranched poly-guano acid shale intercalation inhibitor | 西南石油大学 | 2020-09-04 | — | — | CN | claimed |
| US-20040074504-A1 | Method and composition for inhibiting cardiovascular cell proliferation | COOKE JOHN P (US) | 2004-04-22 | — | — | US | claimed |
| US-6605115-B1 | Method and composition for inhibiting cardiovascular cell proliferation | BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2003-08-12 | — | — | US | claimed |
| US-20030055053-A1 | 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives | PFIZER INC. | 2003-03-20 | — | — | US | claimed |
| JP-2003501393-A | — | — | 2003-01-14 | — | — | JP | claimed |
| EP-1189623-A2 | METHOD AND COMPOSITION FOR INHIBITING CARDIOVASCULAR CELL PROLIFERATION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2002-03-27 | — | — | EP | claimed |
| US-20020016297-A1 | 4-oxo-2- ureido-1,4,5,6,-tetrahydro-pyrimidine derivatives | LINDE ROBERT G (US) | 2002-02-07 | — | — | US | claimed |
| EP-1113008-A1 | 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents | Pfizer Products Inc. (US) | 2001-07-04 | — | — | EP | claimed |
| WO-2000074701-A2 | METHOD AND COMPOSITION FOR INHIBITING CARDIOVASCULAR CELL PROLIFERATION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2000-12-14 | — | — | WO | claimed |
| US-5658885-A | OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-08-19 | — | — | US | claimed |
| EP-4724457-A2 | RADIOPHARMACEUTICAL COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF | Rayzebio, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4724459-A1 | PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF | Peptidream Inc (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-4659691-A | ANTIFERTILITY AGENTS | MERCK & CO., INC. (US) | 1987-04-21 | — | — | US | disclosed |
| EP-0190946-A2 | Novel cyclic hexapeptide LHRH antagonists | MERCK & CO. INC. (US) | 1986-08-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055053-A1 | 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives | UMPS, UPP1, UGP2 | GSR 2888/4885OTC 564/4885NOS2 3729/4885 |
| US-11124818-B2 | Method for modifying microcystins and nodularins | NRDC, NGLY1, NLN | GSR 2455/4885OTC 95/4885NOS2 265/4885 |
| US-20020016297-A1 | 4-oxo-2- ureido-1,4,5,6,-tetrahydro-pyrimidine derivatives | UMPS, UPP1, NUDT1 | GSR 2726/4885OTC 511/4885NOS2 3560/4885 |
| US-20200377922-A1 | METHOD FOR MODIFYING MICROCYSTINS AND NODULARINS | NRDC, NGLY1, NLN | GSR 2627/4885OTC 87/4885NOS2 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.